ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis

Breast Cancer trials near Salt Lake City, UT, USA:

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Talazoparib

Phase 1, Phase 2

Georgetown University
Georgetown University

Salt Lake City, Utah, United States and 1 other location

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Ogden, Utah, United States of America and 226 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 16 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Salt Lake City, Utah, United States and 117 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Enrolling
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

West Valley City, Utah, United States of America and 10 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Ogden, Utah, United States and 147 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Salt Lake City, Utah, United States and 50 other locations

to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combination with Fulvestrant in advanced breast...

Enrolling
Breast Cancer
Advanced Solid Tumor
Drug: CFI-402257
Drug: Fulvestrant

Phase 1, Phase 2

Treadwell Therapeutics

West Valley City, Utah, United States and 3 other locations

be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer. Dose expansion will ...

Enrolling
Metastatic Breast Cancer
Recurrent Ovarian Carcinoma
Drug: Belinostat
Drug: Ribociclib

Phase 1

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States and 1 other location

how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Drug: faslodex dummy
Drug: arimidex dummy

Phase 3

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems